GRDN Guardian Pharmacy Services, Inc.: institutional ownership and insider trading
199 funds reported holding $1.29B of Guardian Pharmacy Services, Inc. in their latest 13F filings; in Q2 2026 funds net bought $51.8M, with 34 new positions and 15 funds selling out; over the last 12 months insiders bought $99.8K and sold $419M on the open market; over its last four quarters it reported revenue of $1.46B and net income of $65.9M.
GRDN revenue and earnings
- Quarter ended Jun 30, 2026: revenue $352M, net income $21.9M
- Quarter ended Mar 31, 2026: revenue $337M, net income $13.3M
- Quarter ended Dec 31, 2025: revenue $398M, net income $20.9M
- Quarter ended Sep 30, 2025: revenue $377M, net income $9.82M
Famous investors holding GRDN
- Izzy Englander (Millennium Management): $5.05M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $4.11M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $4.10M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $3.09M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $1.88M, 0.0% of the portfolio
Largest institutional holders of GRDN
- FMR LLC — $136M
- WELLINGTON MANAGEMENT GROUP LLP — $72.4M
- BlackRock, Inc. (BLK) — $66.0M
- VANGUARD CAPITAL MANAGEMENT LLC — $57.8M
- Woodline Partners LP — $54.7M
- Valiant Capital Management, L.P. — $49.7M
- T. Rowe Price Investment Management, Inc. — $46.8M
- Boston Partners — $40.8M
- VANGUARD GROUP INC — $40.7M
- FRANKLIN RESOURCES INC (BEN) — $40.5M
Recent GRDN insider trades
- Mar 20, 2026: Cardinal Equity Fund, L.P. sold 275,728 shares ($8.18M)
- Mar 20, 2026: Forbes Kendall sold 346,672 shares ($10.3M)
- Mar 20, 2026: Bindley William E sold 3,570,677 shares ($106M)
- Mar 20, 2026: Ackerman John sold 1,103,364 shares ($32.7M)
5%+ owners
- Thomas J. Salentine, Jr.: 26.4% (Schedule 13D/A, filed Sep 28, 2026)
- FMR LLC: 6.5% (Schedule 13G, filed May 6, 2026)